SAN FRANCISCO— Four out of ten patients whose metastatic castration resistant prostate cancer had already been treated with abiraterone responded to further ‘new generation’ androgen deprivation therapy — with enzalutamide — with a PSA decline of at...
AudioMedica News ASCO 2012 ANNUAL MEETING: Outgoing ASCO President Michael Link Comments On Key New Clinical Research Findings Play Episode Pause Episode 1x 00:00 / Subscribe RSS Feed CHICAGO—The outgoing president of ASCO, Dr Michael Link from...
Audio Journal of Oncology Podcast Myelofibrosis: dramatic responses to JAK II R inhibitor ruxolitinib Play Episode Pause Episode 1x 00:00 / 6:31 Subscribe Apple Podcasts Spotify RSS Feed LONDON—Strikingly successful treatment results were reported...
Audio Journal of Oncology Podcast "Total Therapy" Possible Cure For Multiple Myeloma? Play Episode Pause Episode 1x 00:00 / 5:14 Subscribe Apple Podcasts Spotify RSS Feed Bart Barlogie Reporting From: 4th European Congress on Hematologic...
Volker Diehl George Canellos Hodgkin’s Disease: 10-Year Results Show Further Benefit From Escalated BEACOPP Therapy REFERENCE: Abstract 8015, ASCO Annual Meeting Chicago June 1-5, 2007 VOLKER DIEHL, University of Cologne GEORGE CANELLOS, Dana-Farber...
Christian Manegold Roy Herbst More Support for Bevacizumab in Advanced Lung Cancer REFERENCE: Abstract LBA7514, ASCO Annual Meeting Chicago June 1-5, 2007 CHRISTIAN MANEGOLD, Heidelberg University, Mannheim COMMENT: ROY HERBST, MD Anderson Cancer...
Christiane Kuhl Julie Gralow MRI Better Than Mammography for Detecting High-Grade Ductal Carcinoma In Situ? REFERENCE: 1504, ASCO Annual Meeting Chicago June 1-5, 2007 CHRISTIANE KUHL, University of Bonn, Germany COMMENT: JULIE GRALOW, University of...
IAN SMITH, Royal Marsden Hospital, London REFERENCE: Lancet 369:29 Confirmation of the life-extending benefits of trastuzumab adjuvant therapy for early breast cancer has been published recently in the Lancet. Ian Smith gave Peter Goodwin three-year...
Dennis Slamon George Peoples James Holland Massimo Christofanilli Trastuzumab: Mature Results in Early Breast Cancer Show Superiority REFERENCE: San Antonio Breast Cancer Symposium 2006, Abstract: 52 DENNIS SLAMON, University of California, Los...
Martin Müller Charles Linker Andreas Hochhaus Christian Buske Katarina Le Blanc Stephen Emerson Alessandro Vannucchi Kanti Rai Richard Schlenk BCR-ABL Mutations After Imatinib Failure: Impact on Response to Dasatinib REFERENCE: American Society of...
Clifford Hudis Mark Einstein Tony Greco James Berenson Edward Ambinder Breast Cancer: HER2 Still a Useful Target After Trastuzumab Resistance REFERENCE: Chemotherapy Foundation Symposium XXIV 8-11 November 2006 CLIFFORD HUDIS, Memorial Sloan...
Gordon McVie Martine Piccart Bella Kaufman Jean-Yves Douillard ESMO Congress Reviewed GORDON MCVIE, European Institute of Oncology, Milan In Istanbul, Gordon McVie gave his opinion about the achievements of the 2006 European Society for Medical...